Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 7/20 | 0.47 |
| ▸ | L3MBTL1 | Q9Y468 | 5/20 | 0.47 |
| ▸ | NPC1 | O15118 | 4/20 | 0.47 |
| ▸ | RAB9A | P51151 | 4/20 | 0.47 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.47 |
| ▸ | HPGD | P15428 | 3/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.47 |
| ▸ | POLB | P06746 | 2/20 | 0.47 |
| ▸ | CASP1 | P29466 | 2/20 | 0.47 |
| ▸ | CASP7 | P55210 | 2/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.47 |
| ▸ | TP53 | P04637 | 1/20 | 0.47 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | NFKB2 | Q00653 | 1/20 | 0.47 |
| ▸ | RELA | Q04206 | 1/20 | 0.47 |
| ▸ | LTA4H | P09960 | 1/20 | 0.47 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22733855 | 0.98 | DPP4 (0.49) | ALDH1A1L3MBTL1NPC1RAB9AGAA | |
| SCHEMBL12964717 | 0.83 | LTA4H (0.50) | ALDH1A1L3MBTL1NPC1RAB9AGAA | |
| SCHEMBL1478213 | 0.82 | HDAC8 (0.45) | DPP4HDAC8 | |
| SCHEMBL12964715 | 0.82 | DPP4 (0.52) | ALDH1A1L3MBTL1NPC1RAB9AGAA | |
| SCHEMBL14154229 | 0.80 | HDAC8 (0.43) | DPP4HDAC8 | |
| SCHEMBL498548 | 0.80 | LTA4H (0.47) | ALDH1A1L3MBTL1NPC1RAB9AGAA | |
| SCHEMBL22763313 | 0.78 | DPP4 (0.49) | ALDH1A1L3MBTL1NPC1RAB9AGAA | |
| SCHEMBL498818 | 0.78 | DPP4 (0.49) | ALDH1A1L3MBTL1NPC1RAB9AGAA | |
| SCHEMBL18470974 | 0.78 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1NPC1RAB9AGAA | |
| SCHEMBL23611278 | 0.78 | DPP4 (0.65) | ALDH1A1L3MBTL1NPC1RAB9AGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 18 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11352379-B2 | Cyclic germanium compounds and applications thereof | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2022-06-07 | — | — | US | disclosed |
| US-20190225632-A1 | CYCLIC GERMANIUM COMPOUNDS AND APPLICATIONS THEREOF | THE CURATORS OF THE UNIVERSITY OF MISSOURI | 2019-07-25 | — | — | US | disclosed |
| US-10294252-B2 | Cyclic germanium compounds and applications thereof | THE CURATORS OF THE UNIVERSITY OF MISSOURI (US) | 2019-05-21 | — | — | US | disclosed |
| CN-103635482-B | Purposes in cobalt complex active layer in preparing photovoltaic cell and corresponding photovoltaic cell | 国立科学研究中心 | 2016-11-09 | — | — | CN | disclosed |
| US-9263683-B2 | Use of cobalt complexes for preparing an active layer in a photovoltaic cell, and corresponding photovoltaic cell | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2016-02-16 | — | — | US | disclosed |
| EP-2691404-B1 | USE OF COBALT COMPLEXES FOR THE PREPARATION OF THE ACTIVE LAYER OF A PHOTVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | CENTRE NAT RECH SCIENT (FR) | 2015-05-06 | — | — | EP | disclosed |
| US-20140290745-A1 | USE OF COBALT COMPLEXES FOR PREPARING AN ACTIVE LAYER IN A PHOTOVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (FR) | 2014-10-02 | — | — | US | disclosed |
| US-20140290745-A1 | USE OF COBALT COMPLEXES FOR PREPARING AN ACTIVE LAYER IN A PHOTOVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (FR) | 2014-10-02 | — | — | US | disclosed |
| US-20140290745-A1 | USE OF COBALT COMPLEXES FOR PREPARING AN ACTIVE LAYER IN A PHOTOVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | UNIVERSITE PIERRE ET MARIE CURIE (PARIS 6) (FR) | 2014-10-02 | — | — | US | disclosed |
| CN-103635482-A | Use of cobalt complexes for preparing an active layer in a photovoltaic cell, and corresponding photovoltaic cell | CENTRE NAT RECH SCIENT | 2014-03-12 | — | — | CN | disclosed |
| EP-2691404-A1 | USE OF COBALT COMPLEXES FOR PREPARING AN ACTIVE LAYER IN A PHOTOVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | Centre National De La Recherche Scientifique (FR) | 2014-02-05 | — | — | EP | disclosed |
| US-20120264649-A1 | AGENTS FOR ENHANCED CHARGE TRANSPORT ACROSS MICROBIAL MEMBRANES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2012-10-18 | — | — | US | disclosed |
| US-20120264649-A1 | AGENTS FOR ENHANCED CHARGE TRANSPORT ACROSS MICROBIAL MEMBRANES | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2012-10-18 | — | — | US | disclosed |
| WO-2012131257-A1 | USE OF COBALT COMPLEXES FOR PREPARING AN ACTIVE LAYER IN A PHOTOVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-10-04 | — | — | WO | disclosed |
| WO-2012131257-A1 | USE OF COBALT COMPLEXES FOR PREPARING AN ACTIVE LAYER IN A PHOTOVOLTAIC CELL, AND CORRESPONDING PHOTOVOLTAIC CELL | CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) | 2012-10-04 | — | — | WO | disclosed |
| US-5753692-A | PLANT EXTRACTS, IMMUNOSTIMULANTS TREATING IMMUNODEFICIENCY DISEASES | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-19 | — | — | US | disclosed |
| US-5747525-A | ANTITUMOR AGENTS OF OLIGOMERS OF THIOPHENE | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1998-05-05 | — | — | US | disclosed |
| US-5602170-A | ADMINISTERING ANTIIFLAMMATORY AGENT | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 1997-02-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190225632-A1 | CYCLIC GERMANIUM COMPOUNDS AND APPLICATIONS THEREOF | GMNN, DCX, TRPA1 | ALDH1A1 2241/4885L3MBTL1 2062/4885NPC1 3704/4885 |
| US-11352379-B2 | Cyclic germanium compounds and applications thereof | GMNN, DCX, TRPA1 | ALDH1A1 2241/4885L3MBTL1 2062/4885NPC1 3704/4885 |
| US-10294252-B2 | Cyclic germanium compounds and applications thereof | GMNN, DCX, TRPA1 | ALDH1A1 2258/4885L3MBTL1 2160/4885NPC1 3625/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.